Susquehanna Portfolio Strategies’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-73,234
Closed -$1.15M 665
2024
Q1
$1.15M Sell
73,234
-95,061
-56% -$1.47M 0.03% 426
2023
Q4
$2.72M Buy
+168,295
New +$2.75M 0.05% 371

Other funds holding NEO

Susquehanna Portfolio Strategies's NEO Position: Q2 2024 in Review

Susquehanna Portfolio Strategies sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 73,234 shares — an estimated $1.15M sold.

Susquehanna Portfolio Strategies first reported a position in NEO in Q4 2023 and held it in 2 quarters. The position peaked at $2.72M in Q4 2023. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Susquehanna Portfolio Strategies reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 73,234 NeoGenomics shares in Q2 2024, an estimated $1.15M.
  • Susquehanna Portfolio Strategies first reported a position in NeoGenomics in Q4 2023 and held it in 2 quarters.
  • Susquehanna Portfolio Strategies's NeoGenomics position peaked at $2.72M in Q4 2023.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2024, filed 15 Aug 2024.